Tehran University of Medical Sciences

Science Communicator Platform

Share By
Crispr Pioneers Win 2020 Nobel Prize for Chemistry



Farhud DD1, 2, 3 ; Zarifyeganeh M3, 4
Authors

Source: Iranian Journal of Public Health Published:2020

Abstract

Over the last few years, the development of genome editing has revolutionized research on the human genome. Recent advances in developing programmable nucleases, such as meganucleases, ZFNs, TALENs and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas, has greatly expedited the progress of gene editing from concept to clinical practice. The CRISPR has advantages over other nuclease-based genome editing tools due to its high accuracy, efficiency, and strong specificity. Eight years after CRISPR application for human genome edition by Emmanuelle Charpentier and Jennifer A. Doudna, the 2020 Nobel Prize in Chemistry has been jointly given to them for development of CRISPR-Cas9 gene editing, allows scientists to precisely cut and edit of DNA. © 2020, Iranian Journal of Public Health. All rights reserved.
Related Docs
View other Related Docs
1. Crispr Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential, Cell Proliferation (2025)
2. Integrating Crispr/Cas Technology With Clinical Trials: Principles, Progress and Challenges, Asian Journal of Pharmaceutical Sciences (2025)
3. Crispr-Based Gene Editing in Plants: Focus on Reagents and Their Delivery Tools, BioImpacts (2025)
Experts (# of related papers)
View all Related Experts
Fatemeh Radmanesh (2)
Amir Ali Hamidieh (1)
Other Related Docs
4. Implications of Crispr-Cas9 Genome Editing Methods in Atherosclerotic Cardiovascular Diseases, Current Problems in Cardiology (2023)
5. Crispr-Interceded Cho Cell Line Development Approaches, Biotechnology and Bioengineering (2023)
6. The Crispr Growth Spurt: From Bench to Clinic on Versatile Small Rnas, Journal of Microbiology and Biotechnology (2017)
7. Crispr-Cas9 in Basic and Translational Aspects of Cancer Therapy, BioImpacts (2024)
8. Technology Developments in Biological Tools for Targeted Genome Surgery, Biotechnology Letters (2015)
9. Nanoparticles-Mediated Crispr/Cas9 Delivery: Recent Advances in Cancer Treatment, Journal of Drug Delivery Science and Technology (2020)
10. Targeting Mrna-Coding Genes in Prostate Cancer Using Crispr/Cas9 Technology With a Special Focus on Androgen Receptor Signaling, Cell Communication and Signaling (2024)
11. Saponin and Fluorine-Modified Polycation As a Versatile Gene Delivery System, Nanotechnology (2022)
12. The Significance of Bioengineered Nanoplatforms Against Sars-Cov-2: From Detection to Genome Editing, Life Sciences (2021)
13. Synthesis and Characterization of Vitamin D3-Functionalized Carbon Dots for Crispr/Cas9 Delivery, Nanomedicine (2021)
14. Crispr-Cas9-Mediated Gene Therapy in Lung Cancer, Clinical and Translational Oncology (2023)
15. Exploring Non-Viral Methods for the Delivery of Crispr-Cas Ribonucleoprotein to Hematopoietic Stem Cells, Stem Cell Research and Therapy (2024)
16. Car-Nk Cells for Haematological Cancers, Best Practice and Research: Clinical Haematology (2025)
17. Polyethylenimine-Functionalized Carbon Dots for Delivery of Crispr/Cas9 Complexes, ACS Applied Bio Materials (2021)
18. Vector and Cell Line Engineering Technologies Toward Recombinant Protein Expression in Mammalian Cell Lines, Applied Biochemistry and Biotechnology (2018)
19. Combination of Genetics and Nanotechnology for Down Syndrome Modification: A Potential Hypothesis and Review of the Literature, Iranian Journal of Public Health (2019)
20. Genetic Disruption of the Klf1 Gene to Overexpress the Γ-Globin Gene Using the Crispr/Cas9 System, Journal of Gene Medicine (2016)